Sleep disturbances in drug naïve Parkinson's disease (PD) patients and effect of levodopa on sleep

Annals of Indian Academy of Neurology

Volumn 17, Issue 4, 2014, Pages 416-419

  Ferreira, Teresa ^a   Prabhakar, Sudesh ^a   Kharbanda, Parampreet S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Levodopa on Parkinson's disease sleep; levodopa on sleep; sleep in Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AROUSAL; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DRUG DOSE TITRATION; EPWORTH SLEEPINESS SCALE; HUMAN; MUSCLE RIGIDITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONREM SLEEP; PARKINSON DISEASE; PARKINSON'S DISEASE SLEEP SCALE; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PROSPECTIVE STUDY; REM SLEEP; RESTLESS LEGS SYNDROME; SLEEP; SLEEP DISORDER; SLEEP QUALITY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 84911129945     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.144016     Document Type: Article

References (13)

1. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990;5:280-5.
2. Kales A, Ansel RD, Markham CH, Scharf MB, Tan TL. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971;12:397-406.
3. Shpirer I, Miniovitz A, Klein C, Goldstein R, Prokhorov T, Theitler J, et al. Excessive daytime sleepiness in patients with Parkinson's disease: A polysomnography study. Mov Disord 2006;21:1432-8.
4. Diederich NJ, Vaillant M, Mancuso G, Lyen P, Tiete J. Progressive sleep 'destructuring' in Parkinsons disease. A polysomnographic study in 46 patients. Sleep Med 2005;6:313-8.
5. Dhawan V, Dhoat S, Williams AJ, Dimarco A, Pal S, Forbes A, et al. The range and nature of sleep dysfunction in untreated Parkinson's diasease (PD). A comparative controlled clinical study using the Parkinsons disease sleep scale and selective polysomnography. J Neurol Sci 2006;248:158-62.
6. Nicholson AN, Pascoe PA. Dopaminergic transmission and the sleep-wakefulness continiuum in man. Neuropharmacology 1990;29:411-7.
7. van Hilten B, Hoff JI, Middelkoop HA, van der Velde EA, Kerkhof GA, Wauguier A, et al. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch Neurol 1994;51:922-8.
8. Askenasy JJ, Yahr MD. Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: A preliminary study. Neurology 1985;35:527-32.
9. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55;181-4.
10. Chaudhuri KR, Pal S, Dimarco A, Whately-Smith C, Bridgman K, Mathew R, et al. The Parkinson's disease sleep scale: A new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629-35.
11. Johns M, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep 1997;20:844-9.
12. Iber C, Ancoli-Israel S, Chessonn A, Quan SF. In The AASM Manual for the scoring of sleep and associated events: Rules, terminology and technical specifications. 1st ed. Westchester: American Academy of Sleep Medicine; 2007.
13. Yoshimura N, Mizuta E, Yoshida O, Kuno S. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1, 2, 3, 6-Tetrahydropyridine-lesioned parkinsoniancynomolgus monkeys. J Pharmacol Exp Ther 1998;286:228-33.